Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Am J Emerg Med ; 34(1): 114.e3-4, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26008583

RESUMO

Central venous catheterization is often necessary for the safe administration of medications that are caustic to peripheral veins, to place temporary transvenous pacemakers and to provide invasive hemodynamic monitoring in the critically ill. While a wide range of complications are known to occur with insertion of these catheters, there is a paucity of cases associated with cardiac arrest during the catheters placement. We describe an unusual case of sustained ventricular tachycardia and subsequent cardiac arrest that occurred during an ultrasound guided central venous catheter placement for a patient in septic shock. This case serves as a reminder of the rare, but potentially fatal complication of central venous access placement.


Assuntos
Cateterismo Venoso Central/efeitos adversos , Parada Cardíaca/etiologia , Taquicardia Ventricular/etiologia , Idoso , Diagnóstico Diferencial , Parada Cardíaca/diagnóstico , Parada Cardíaca/terapia , Humanos , Masculino , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/terapia
2.
J Neurol Sci ; 449: 120647, 2023 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-37100017

RESUMO

We examined whether conflicting visual and non-visual information leads to gait abnormalities and how the subthalamic deep brain stimulation (STN DBS) influences gait dysfunction in Parkinson's disease (PD). We used a motion capture system to measure the kinematics of the lower limbs during treadmill walking in immersive virtual reality. The visual information provided in the virtual reality paradigm was modulated to create a mismatch between the optic-flow velocity of the visual scene and the walking speed on the treadmill. In each mismatched condition, we calculated the step duration, step length, step phase, step height, and asymmetries. The key finding of our study was that mismatch between treadmill walking speed and the optic-flow velocity did not consistently alter gait parameters in PD. We also found that STN DBS improved the PD gait pattern by changing the stride length and step height. The effects on phase and left/right asymmetry were not statistically significant. The DBS parameters and location also determined its effects on gait. Statistical effects on stride length and step height were noted when the DBS volume of activated tissue (VTA) was in the dorsal aspect of the subthalamus. The statistically significant effects of STN DBS was present when VTA significantly overlapped with MR tractogrphically measured motor and pre-motor hyperdirect pathways. In summary, our results provide novel insight into ways for controlling walking behavior in PD using STN DBS.


Assuntos
Estimulação Encefálica Profunda , Doença de Parkinson , Núcleo Subtalâmico , Humanos , Doença de Parkinson/complicações , Doença de Parkinson/terapia , Estimulação Encefálica Profunda/métodos , Núcleo Subtalâmico/fisiologia , Marcha/fisiologia , Caminhada
4.
Artigo em Inglês | MEDLINE | ID: mdl-28954802

RESUMO

BACKGROUND: Hospital evaluation of patients with chest pain is common and costly. The HEART score risk stratification tool that merges troponin testing into a clinical risk model for evaluation emergency department patients with possible acute myocardial infarction (AMI) has been shown to effectively identify a substantial low-risk subset of patients possibly safe for early discharge without stress testing, a strategy that could have tremendous healthcare savings implications. METHOD AND RESULTS: A total of 105 patients evaluated for AMI in the emergency departments of 2 teaching hospitals in the Henry Ford Health System (Detroit and West Bloomfield, MI), between February 2014 and May 2015, with a modified HEART score ≤3 (which includes cardiac troponin I <0.04 ng/mL at 0 and 3 hours) were randomized to immediate discharge (n=53) versus management in an observation unit with stress testing (n=52). The primary end points were 30-day total charges and length of stay. Secondary end points were all-cause death, nonfatal AMI, rehospitalization for evaluation of possible AMI, and coronary revascularization at 30 days. Patients randomized to early discharge, compared with those who were admitted for observation and cardiac testing, spent less time in the hospital (median 6.3 hours versus 25.9 hours; P<0.001) with an associated reduction in median total charges of care ($2953 versus $9616; P<0.001). There were no deaths, AMIs, or coronary revascularizations in either group. One patient in each group was lost to follow-up. CONCLUSIONS: Among patients evaluated for possible AMI in the emergency department with a modified HEART score ≤3, early discharge without stress testing as compared with transfer to an observation unit for stress testing was associated with significant reductions in length of stay and total charges, a finding that has tremendous potential national healthcare expenditure implications. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT03058120.


Assuntos
Angina Pectoris/diagnóstico , Técnicas de Apoio para a Decisão , Eletrocardiografia , Tempo de Internação , Infarto do Miocárdio/diagnóstico , Alta do Paciente , Triagem , Troponina I/sangue , Adulto , Fatores Etários , Idoso , Angina Pectoris/sangue , Angina Pectoris/economia , Angina Pectoris/terapia , Biomarcadores/sangue , Causas de Morte , Redução de Custos , Análise Custo-Benefício , Serviço Hospitalar de Emergência , Feminino , Custos Hospitalares , Hospitais Universitários , Humanos , Tempo de Internação/economia , Masculino , Michigan , Pessoa de Meia-Idade , Infarto do Miocárdio/sangue , Infarto do Miocárdio/economia , Infarto do Miocárdio/terapia , Revascularização Miocárdica , Alta do Paciente/economia , Readmissão do Paciente , Valor Preditivo dos Testes , Estudos Prospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Triagem/economia
5.
Genome Biol ; 15(3): R53, 2014 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-24667040

RESUMO

BACKGROUND: There is tremendous potential for genome sequencing to improve clinical diagnosis and care once it becomes routinely accessible, but this will require formalizing research methods into clinical best practices in the areas of sequence data generation, analysis, interpretation and reporting. The CLARITY Challenge was designed to spur convergence in methods for diagnosing genetic disease starting from clinical case history and genome sequencing data. DNA samples were obtained from three families with heritable genetic disorders and genomic sequence data were donated by sequencing platform vendors. The challenge was to analyze and interpret these data with the goals of identifying disease-causing variants and reporting the findings in a clinically useful format. Participating contestant groups were solicited broadly, and an independent panel of judges evaluated their performance. RESULTS: A total of 30 international groups were engaged. The entries reveal a general convergence of practices on most elements of the analysis and interpretation process. However, even given this commonality of approach, only two groups identified the consensus candidate variants in all disease cases, demonstrating a need for consistent fine-tuning of the generally accepted methods. There was greater diversity of the final clinical report content and in the patient consenting process, demonstrating that these areas require additional exploration and standardization. CONCLUSIONS: The CLARITY Challenge provides a comprehensive assessment of current practices for using genome sequencing to diagnose and report genetic diseases. There is remarkable convergence in bioinformatic techniques, but medical interpretation and reporting are areas that require further development by many groups.


Assuntos
Bases de Dados Genéticas/normas , Testes Genéticos/métodos , Genômica/métodos , Revisão da Pesquisa por Pares , Análise de Sequência de DNA/métodos , Criança , Feminino , Organização do Financiamento , Testes Genéticos/economia , Testes Genéticos/normas , Genômica/economia , Genômica/normas , Cardiopatias Congênitas/diagnóstico , Cardiopatias Congênitas/genética , Humanos , Masculino , Miopatias Congênitas Estruturais/diagnóstico , Miopatias Congênitas Estruturais/genética , Análise de Sequência de DNA/economia , Análise de Sequência de DNA/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA